Antiresorptive Medications and MRONJ

Date: Tuesday, May 13, 2025
Time: 8 p.m. to 9:30 p.m.

Location:




Important Zoom  Instructions:

 

University of Maryland School of Dentistry - Live Webinar via Zoom
Log into this meeting from the comfort of your home or office. Webinars are best viewed on a desktop computer or laptop. If viewing on a mobile device, the Zoom app will need to be downloaded on the device.

 

Soon after registering, you will receive your confirmation email. Please click the link provided in your confirmation to complete your Zoom registration. Once you complete the Zoom registration, you will receive Zoom meeting reminders 1 week, 1 day, and 1 hour before the course. 
Tuition: Dental Professionals: $59.00
Credits:

1.5 CDE credit hours - lecture

The University of Maryland School of Dentistry designated this activity for 1.5 Continuing Dental Education hours.
Target Audience:  All dental professionals
Presented by:

Douglas W. Beals, DDS, MS
Conflict of Interest: Nothing to disclose.

 

Register Here

Speaker Biography

Beals

Dr. Beals received his Bachelor of Science degree in 1988, his Doctorate of Dental Surgery degree in 1993 and his Master of Science degree in 1997 from The Ohio State University. He entered private practice in Scottsdale, Arizona in 1997. He is a Board Certified Oral and Maxillofacial Surgeon and a fellow of the American Association of Oral and Maxillofacial Surgeons.

Dr. Beals is currently an Associate Professor Oral Surgery at Midwestern University, College of Dental Medicine – Arizona. Dr. Beals joined the clinical faculty in 2015.

 

Course Description

This presentation provides an overview of Osteonecrosis of the Jaw (ONJ) and Medication-Related Osteonecrosis of the Jaw (MRONJ), focusing on understanding its types, definitions, causes, and management strategies. Participants will learn to identify and describe the three primary types of ONJ and the core elements that define MRONJ.  Dr. Beals will cover the indications for antiresorptive medications, exploring the mechanisms of action for drugs like Denosumab and Bisphosphonates, and detailing both anabolic and anti-catabolic medication categories.

Additionally, the presentation will cover the pathophysiology, stages, and predisposing factors of MRONJ, providing a solid foundation for understanding its progression and impact. It will also address treatment goals, the American Association of Oral and Maxillofacial Surgeons (AAOMS) guidelines, and local wound care practices that promote healing.

Participants will examine the "4 Ds" of antiresorptive therapy, the delayed dosing protocol, and specialized decision-making tools, such as the extraction and MRONJ decision trees for Complex Dental Management and Assessment (CDMA) cases. Through these elements, the presentation aims to equip learners with practical strategies and evidence-based approaches for managing MRONJ in clinical settings.

Course Objectives

At the conclusion of this course the participants should be able to:

  • Identify and describe Osteonecrosis of the Jaw (ONJ) and Medication-Related ONJ (MRONJ)
  • Explain the mechanisms of action and therapeutic uses of medication involved in managing Osteonecrosis of the Jaw, ONJ, including antieresorptive and anabolic agents.
  • Discuss antiresorptive therapy and its guidelines.
  • Recognize predisposing factors and treatment goals in MRONJ.
  • Apply decision-making tools for extraction and MRONJ.

Cancellation and Refund Policies

Cancellation and Refund Policies